Phillip J. Koo, MD

home / authors / phillip-j-koo-md

Articles

Dr Koo on the Clinical Utility of PSMA PET in Prostate Cancer

Phillip J. Koo, MD

April 11th 2024

Phillip J. Koo, MD, discusses the clinical use of PSMA PET imaging in patients with prostate cancer.

Dr Koo on PSMA PET Imaging in Prostate Cancer

Phillip J. Koo, MD

March 26th 2024

Phillip J. Koo, MD, discusses the use of PSMA PET imaging in prostate cancer.

Dr. Koo on Novel Technological and Therapeutic Advancements in Prostate Cancer

Phillip J. Koo, MD

March 1st 2023

Phillip J. Koo, MD, discusses ongoing areas of technological and therapeutic advancements within the prostate cancer landscape.

PSMA-Targeted 18F-DCFPyL PET/CT in High-Risk Prostate Cancer

Alicia K. Morgans, MD, MPH, Robert H. Lurie Comprehensive Cancer Center of Northwestern University;Scott T. Tagawa, MD, MS, FACP, Weill Cornell Medicine;Phillip J. Koo, MD

August 23rd 2021

An interpretation of the OSPREY study of 18F-DCFPyL injection in patients with high-risk prostate cancer and implications of its use.

Phenotypic Biomarkers in Advanced Prostate Cancer

Alicia K. Morgans, MD, MPH, Robert H. Lurie Comprehensive Cancer Center of Northwestern University;Phillip J. Koo, MD;Sandy Srinivas, MD, Stanford University Medical Center

August 23rd 2021

A discussion regarding the use of PSMA PET imaging to detect phenotypic biomarkers that may simplify approaches to precision medicine in advanced prostate cancer.

Dr. Koo on the Need for Next-Generation Imaging in Prostate Cancer

Phillip J. Koo, MD

May 16th 2020

Phillip J. Koo, MD, discusses the need for next-generation imaging in prostate cancer.

Dr. Koo on the Actionability of Next-Generation Imaging Results in Prostate Cancer

Phillip J. Koo, MD

January 29th 2020

Phillip J. Koo, MD, division chief of Diagnostic Imaging, Banner MD Anderson Cancer Center, discusses the actionability of next-generation imaging results in prostate cancer.

Dr. Koo on Metastasis-Directed Therapy in Prostate Cancer

Phillip J. Koo, MD

January 21st 2020

Phillip J. Koo, MD, division chief of Diagnostic Imaging, Banner MD Anderson Cancer Center, discusses the use of metastasis-directed therapy in prostate cancer.